ProQR Therapeutics N.V. (PRQR): key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- €15.9M
- Net Income/Loss (FY2025)
- -€42.2M
- Total Assets (FY2025)
- €112.8M
- Total Equity (FY2025)
- €49.4M
- Cash Flows from Operating Activities (FY2025)
- -€52.8M
Source: ProQR Therapeutics N.V. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
